Italian pharmaceutical company Cosmo Pharmaceuticals recently announced that its newly developed male-pattern hair loss ...

Southwest Research Institute (SwRI) and Trinity University are developing an intranasal (IN) drug-device combination to treat ...

An organoid standard working group has recently been established, with Chinese scholars leading the effort to gather international expertise to develop a strategic plan and advance standard ...

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for TRN-257, a controlled-release, low-sodium oxybate product, for the treatment of cataplexy or excessive ...

VANCOUVER, BC / ACCESS Newswire / December 9, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is advancing the development of a next-generation "Melt in Your ...

The field of dermatology has witnessed remarkable progress in the prevention and treatment of skin diseases over the past ...

The approval of Emeprev will help veterinary professionals by providing an in-clinic antiemetic option.

When referring to this article, please cite it as Hennessy, M. How Innovation and Risk Management Are Reshaping Modern Drug ...

Drug discovery is a high-risk, high-cost endeavor, with over 90% of candidates failing in clinical development. A significant proportion of these ...

The Central Drugs Standard Control Organisation (CDSCO) is considering introducing new rules to stop the industry practice of ...

The pharmaceutical supply chain and device development have become intricately linked. Harmonizing formulation development ...